載脂蛋白M(APOM)多克隆抗體
Polyclonal Antibody to Apolipoprotein M (APOM)
Apo-M; G3a; NG20; Protein G3a
- 編號PAC299Po01
- 物種Sus scrofa; Porcine (Pig，豬) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPC299Po01-載脂蛋白M(APOM)重組蛋白
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 756 ¥ 1764 ¥ 2520 ¥ 6300 ¥ 25200
- 欲了解實際交易價格和更多情況，請與當?shù)亟涗N商聯(lián)系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
DAB staining on IHC-P;
Sample: Porcine Liver Tissue
Primary Ab: 10μg/ml Rabbit Anti-Porcine APOM Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant APOM, Pig.
-
Western Blot; Samples: Lane1: Porcine Serum; Lane2: Porcine Plasma;
Primary Ab: 0.1μg/ml Rabbit Anti-Porcine APOM Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
-
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對APOM的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別APOM。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產品
| 編號 | 適用物種：Sus scrofa; Porcine (Pig，豬) | 應用(僅供研究使用，不用于臨床診斷！) |
| NPC299Po01 | 載脂蛋白M(APOM)天然蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC299Po01 | 載脂蛋白M(APOM)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAC299Po01 | 載脂蛋白M(APOM)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC299Po71 | 載脂蛋白M(APOM)多克隆抗體(生物素標記) | WB; IHC; ICC. |
參考文獻
| 雜志 | 參考文獻 |
| Joint Bone Spine | Apolipoprotein m (APOM) levels and APOM rs805297 G/T polymorphism are associated with increased risk ofrheumatoid arthritis [Pubmed: 23660425] |
| Apoptosis | The miR-573/apoM/Bcl2A1-dependent signal transduction pathway is essential for hepatocyte apoptosis and hepatocarcinogenesis [PubMed: 26201458] |
| Lipids in Health and Disease | Effects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case–control study [pubmed:27633510] |
| Lipids in Health and Disease | A single-nucleotide polymorphism C-724 /del in the proter region of the apolipoprotein M gene is associated with type 2 diabetes mellitus [pubmed:27576735] |
| clinica chimica acta | ApoM/HDL-C and apoM/apoA-I ratios are indicators of diabetic nephropathy in healthy controls and type 2 diabetes mellitus. [pubmed:28073663] |
| International Journal of Clinical and Experimental Pathology | Level of serum apolipoprotein m and its diagnostic significance in inflammatory bowel disease [files:ijcep0033416.pdf] |
| Scandinavian Journal of Medicine &?Science?in?Sports | Endurance training selectively increases HDL-bound sphingosine-1-phosphate in the plasma [pubmed:28493600] |
| INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY | HDL-S1P Protects Endothelial Function and Reduces Lung Injury During Sepsis in vivo and in vitro [Pubmed: 32750426] |
| Biology-Basel | Biomechanical Properties of Blood Plasma Extracellular Vesicles Revealed by Atomic Force Microscopy [33374530] |
| researchsquare | Apolipoprotein M in High Density Lipoprotein Protects Against Astrocyte Apoptosis Induced By Ischemic Insult Via Sphingosine 1-Phosphate Signaling [] |
留言咨詢
